-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Haemonetics Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2009 to 2023.
- Haemonetics Corp Income Tax Expense (Benefit) for the quarter ending June 29, 2024 was $8.34M, a 20.9% decline year-over-year.
- Haemonetics Corp Income Tax Expense (Benefit) for the twelve months ending June 29, 2024 was $32.1M, a 3.77% increase year-over-year.
- Haemonetics Corp annual Income Tax Expense (Benefit) for 2023 was $34.3M, a 31.9% increase from 2022.
- Haemonetics Corp annual Income Tax Expense (Benefit) for 2022 was $26M, a 28.4% increase from 2021.
- Haemonetics Corp annual Income Tax Expense (Benefit) for 2021 was $20.3M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)